The end of the year is here!We would like to thank you for your interest and trust!Our team wishes you a wonderful festive season and remains at your disposal during this period.
Have a wonderful holiday season!
30/12/2022
EudraVigilance user declaration for qualified persons for pharmacovigilance / responsible persons for EudraVigilance update
21/12/2022
EudraVigilance is the centralized European database of suspected adverse reactions to medicines that are authorized or being studied in clinical trials in the European Economic Area (EEA). It is used by national competen
Biosimilar medicines are interchangeable
21/09/2022
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) decided to harmonise EU position on interchangeability of biological medicines by issuing a joint statement confirming that biosimilar medicines approve
Qualified Person deputy in France
15/09/2022
The status of Responsible Pharmacist in a pharmaceutical company is specific to France and is regulated by the Public Health Code (CSP).In France, any company with at least one pharmaceutical establishment must be owned by a pharm
How clinical trials are changing in Europe
01/09/2022
Clinical trials in human medicines are studies carried out in human volunteers intended to investigate the safety or efficacy of one or more investigational medicines.Clinical trials can only be started after a compound has passed